Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Schizophrenia

Free Subscription 04.05.2025 1 Br J Psychiatry 1 Can J Psychiatry 1 Cereb Cortex 1 Psychiatry Res 3 Psychol Med 6 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Br J Psychiatry

1. SHAJU A, Mishra A, Mohapatra D, Srinivasan A, et al
   Efficacy and safety of cholinergic modulators in patients with schizophrenia: meta-analysis of randomised controlled trials.
   Br J Psychiatry. 2025 May 2:1-11. doi: 10.1192/bjp.2025.
   PubMed         Abstract available
   
   

   
   Can J Psychiatry

2. ROTENBERG M, Graffi J, Anderson K, Kurdyak P, et al
   A Geospatial Analysis of Early Psychosis Intervention Programs in Toronto, Canada: Une analyse geospatiale des programmes d'intervention precoce en cas de psychose a Toronto, au Canada.
   Can J Psychiatry. 2025 Apr 29:7067437251337807. doi: 10.1177/07067437251337807.
   PubMed         Abstract available
   
   

   
   Cereb Cortex

3. LUO Y, Zhu T, Zhang Y, Fan J, et al
   Association of core brain networks with antipsychotic therapeutic effects in first-episode schizophrenia.
   Cereb Cortex. 2025;35:bhaf088.
   PubMed         Abstract available
   
   

   
   Psychiatry Res

4. PELIZZA L, Leuci E, Quattrone E, Palmisano D, et al
   Compulsory admission as access to early intervention service for patients with first episode psychosis: What relevance for clinical outcomes? Further findings from the Pr-EP program.
   Psychiatry Res. 2025;349:116507.
   PubMed         Abstract available
   
   

   
   Psychol Med

5. SERIMAA O, Keltikangas-Jarvinen L, Lyytikainen LP, Hietala J, et al
   Polygenic risk for schizophrenia and subjective well-being in a general population sample.
   Psychol Med. 2025;55:e133.
   PubMed         Abstract available
   
   
6. FENG Y, Wong KC, Leung PB, Lee BK, et al
   Longitudinal impact of different treatment sequences of second-generation antipsychotics on metabolic outcomes: a study using targeted maximum likelihood estimation.
   Psychol Med. 2025;55:e123.
   PubMed         Abstract available
   
   
7. JEON E, Li L, Le TH, Kim WS, et al
   Virtual reality therapy targeting ideas of reference in patients with psychosis: a single-blind parallel-group randomized controlled trial.
   Psychol Med. 2025;55:e121.
   PubMed         Abstract available
   
   

   
   Schizophr Res

8. JIA N, Yin X, Zhu Z, Hou W, et al
   Comprehensive transcriptome analysis and lncRNA-miRNA-mRNA establishment of schizophrenia based on induced pluripotent stem cells.
   Schizophr Res. 2025;281:22-29.
   PubMed         Abstract available
   
   
9. 
   Commentary on "Speaking of yourself: A meta-analysis of 80 years of research on pronoun use in schizophrenia".
   Schizophr Res. 2025;281:20-21.
   PubMed        
   
   
10. RAMIREZ-BERMUDEZ J, Espinola-Nadurille M, Restrepo-Martinez M, Martinez-Angeles V, et al
    Autoimmune psychosis: Psychopathological patterns and outcome after immunotherapy.
    Schizophr Res. 2025;281:10-19.
    PubMed         Abstract available
    
    
11. TRUJILLO T, Mirzakhanian H, Addington J, Bearden CE, et al
    High rates of suicidality and parasuicidal behavior in individuals at clinical high-risk for psychosis: Implications for suicide risk assessment and suicide prevention.
    Schizophr Res. 2025;281:1-9.
    PubMed         Abstract available
    
    
12. SALUJA A, Johnson KA, Ongur D, Lanca M, et al
    Changes in first-episode psychosis care delivery and outcomes throughout the COVID-19 pandemic: Insights from a learning healthcare system in Massachusetts.
    Schizophr Res. 2025;280:130-139.
    PubMed         Abstract available
    
    
13. ZHU B, Liang L, Huang Y, Wang H, et al
    Exploring the relationship between the gut microbiota and cognitive function in schizophrenia patients with distinct weights.
    Schizophr Res. 2025;280:103-113.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.